Melanoma Drug Works in Other Tumors
- PMID: 26385779
- DOI: 10.1158/2159-8290.CD-NB2015-131
Melanoma Drug Works in Other Tumors
Abstract
In a phase II basket trial, vemurafenib, an enzyme inhibitor prescribed for certain BRAF V600-mutant melanomas, proved effective in some nonmelanoma cancers that also carried a BRAF V600 mutation.
©2015 American Association for Cancer Research.
Comment on
-
Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations.N Engl J Med. 2015 Aug 20;373(8):726-36. doi: 10.1056/NEJMoa1502309. N Engl J Med. 2015. PMID: 26287849 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
